HOME >> BIOLOGY >> NEWS
New Cell titles further ScienceDirect offering

Amsterdam, March 14, 2007 -- This year, Elsevier, a leading publisher of scientific, technical and medical (STM) information, is adding two new, groundbreaking Cell Press titles - Cell Host & Microbe and Cell Stem Cell to its platform, ScienceDirect. To celebrate the launch, access to the first three issues of both journals is complimentary for three months.

A requisite addition to the Cell Press collection on ScienceDirect, which includes leading titles Cell and Neuron, Cell Host & Microbe and Cell Stem Cell will be valuable resources for specialists in microbiology and stem cell biology.

Cell Host & Microbe - available on ScienceDirect from March 14, 2007 - will provide a forum for the exchange of ideas and concepts between scientists studying the microbe with those studying the host immune and cellular response upon colonization or infection by a microbe. The journal will publish findings related to microbes, from molecular and cellular biology to translational studies, with particular emphasis on the interface between the microbe and its host. The unifying theme will be the integrated study of microbes in conjunction and communication with each other, their host and the cellular environment they live in.

Cell Stem Cell - available on ScienceDirect from June 6, 2007 - will cover the entire spectrum of stem cell biology. The journals goal will be to provide a forum for the publication of leading stem cell research and the exchange of ideas between scientists working in the burgeoning field of stem cell biology. Cell Stem Cell will be the official affiliated journal of the International Society for Stem Cell Research (ISSCR).

"Continuing to build on the extensive collection of high-quality content already available on ScienceDirect is one of our highest priorities," said Joep Verheggen, Director of ScienceDirect. "I am particularly pleased with the forthcoming inclusion of Cell Host & Microbe and Cell Stem
'"/>

Contact: Juliette Goetzee
j.goetzee@elsevier.com
31-020-485-2893
Elsevier
14-Mar-2007


Page: 1 2

Related biology news :

1. New titles focus on food safety: Fresh produce and tracking contamination
2. 1 in 8 of Thomson Scientifics 2005 Top 40 hottest papers from three Oxford Journals titles
3. Complementary new titles offer comprehensive view of antibiotics and resistance
4. Lucky 13 as new gene discovery offers further hope for childhood blindness
5. Can further studies lower the cost of preserving vision?
6. Woods Hole Research Center scientist furthering discussion of soil carbon decomposition
7. Human trial proves ricin vaccine safe, induces neutralizing antibodies; further tests planned
8. ASU researcher fashions DNA to further advances in nanotechnology
9. Ancient olfaction protein is shared by many bugs, offering new pest control target

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:8/26/2020)... ... August 25, 2020 , ... ... pharmaceuticals targeting mitochondria, in partnership with Essex Bio-Technology, a bio-pharmaceutical company specializing ... Phase 3 VISTA-2 study of SkQ1 ophthalmic solution in patients with moderate ...
(Date:8/26/2020)... ... 2020 , ... Modality Solutions, a biopharmaceutical cold chain validation engineering ... The list is the most prestigious ranking of the nation’s fastest-growing private companies. Modality ... list, reported three-year revenue growth of 71 percent. , The Inc. 5000 list ...
(Date:8/21/2020)... ... August 18, 2020 , ... Sentien Biotechnologies, Inc., a ... U.S. Food and Drug Administration (FDA) has approved the company’s Investigational New Drug ... of severe COVID-19. Approval of this IND allows Sentien to initiate a Phase ...
Breaking Biology News(10 mins):
(Date:7/31/2020)... ... July 30, 2020 , ... ... sciences industry, today announced the release of its signature product called Beacon ... Liaisons (MSLs) and other field medical professionals. , Beacon helps MSLs ...
(Date:7/18/2020)... ... July 17, 2020 , ... dicentra ... life sciences and food industries, is pleased to announce that Charles Galea has ... Business Development. , Charles is an accomplished and results-driven sales executive with over ...
(Date:7/7/2020)... ... , ... R3 International is now offering stem cell therapy for Alzheimers dementia ... on the patient's condition, treatment may be offered IV, intrathecal or with a combination. ... Alzheimers dementia, and the incidence continues to increase as individuals live longer. There is ...
(Date:6/28/2020)... ... June 25, 2020 , ... The Indoor Lab, a ... Safe Space™ for businesses of all types to ensure cleanliness, distancing and occupancy with ... , A Safe Space™ enabled business will provide a health performance index system that ...
Breaking Biology Technology:
Cached News: